At a glance
- Originator Merck & Co
- Class Antifungals
- Mechanism of Action Sphingosine N-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 03 Nov 1998 No-Development-Reported for Mycoses in Spain (Unknown route)
- 03 Nov 1998 No-Development-Reported for Mycoses in USA (Unknown route)
- 11 Dec 1995 New profile